GCI bags Novartis’ social media director
pharmafile | November 8, 2010 | Appointment | Medical Communications | GCI Health, Mark Davis, Novartis, appointment, medical communications
Novartis Pharmaceuticals’ former social media director Mark Davis has moved to GCI Health.
He has been appointed to lead the US-based PR agency’s digital health team and will also join GCI’s leadership team.
“Digital solutions offer breakthrough opportunities to influence healthcare opinion and behaviour, build better, more direct communications and ultimately, drive brand visibility and uptake,” said Davis.
“Integrating social media and other emerging channels creates unique avenues to truly communicate and engage with patients and healthcare providers instantaneously enhancing more traditional communications efforts.”
During his time at Novartis Mark he developed the pharma company’s organisational capabilities for social media. These included regulatory and legal standard operating procedures, as well as a strategic brand opportunity framework which guided social media prioritisation and development across all brands.
Earlier in his career at Novartis, Mark was a director in the company’s integrated marketing solutions group.
“Mark understands the changing and growing needs of our clients and the marketplace as digital channels continue to profoundly shift the nature of communications in our industry,” said chief executive Wendy Lund. “Adding his expertise is another example of our dedication to offering our clients top talent and unsurpassed work.”
GCI Health recently launched a new practice – Synchronicity – that will focus on novel avenues in patient education in which digital health will play a prominent role.
Related Content
Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …
Novartis receives SMC approval for early breast cancer treatment
Novartis has announced that its treatment for early breast cancer, Kisqali (ribociclib), has received approval …
PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …
